Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

SNPs and breast cancer risk prediction for African American and Hispanic women.

Breast cancer research and treatment | 2015

For African American or Hispanic women, the extent to which clinical breast cancer risk prediction models are improved by including information on susceptibility single nucleotide polymorphisms (SNPs) is unknown, even though these women comprise increasing proportions of the US population and represent a large proportion of the world's population. We studied 7539 African American and 3363 Hispanic women from the Women's Health Initiative. The age-adjusted 5-year risks from the BCRAT and IBIS risk prediction models were measured and combined with a risk score based on >70 independent susceptibility SNPs. Logistic regression, adjusting for age group, was used to estimate risk associations with log-transformed age-adjusted 5-year risks. Discrimination was measured by the odds ratio (OR) per standard deviation (SD) and the area under the receiver operator curve (AUC). When considered alone, the ORs for African American women were 1.28 for BCRAT, and 1.04 for IBIS. When combined with the SNP risk score (OR 1.23), the corresponding ORs were 1.39 and 1.22. For Hispanic women the corresponding ORs were 1.25 for BCRAT, and 1.15 for IBIS. When combined with the SNP risk score (OR 1.39), the corresponding ORs were 1.48 and 1.42. There was no evidence that any of the combined models were not well calibrated. Including information on known breast cancer susceptibility loci provides approximately 10 and 19% improvement in risk prediction using BCRAT for African Americans and Hispanics, respectively. The corresponding figures for IBIS are approximately 18 and 26%, respectively.

Pubmed ID: 26589314 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: PHS HHS, United States
    Id: 32105-6
  • Agency: NCI NIH HHS, United States
    Id: P30 CA015704
  • Agency: PHS HHS, United States
    Id: 42107-26
  • Agency: PHS HHS, United States
    Id: 32115
  • Agency: PHS HHS, United States
    Id: 32100-2
  • Agency: PHS HHS, United States
    Id: 24152
  • Agency: PHS HHS, United States
    Id: 42129-32
  • Agency: PHS HHS, United States
    Id: 32118-32119
  • Agency: PHS HHS, United States
    Id: 32108-9
  • Agency: PHS HHS, United States
    Id: 32122
  • Agency: PHS HHS, United States
    Id: 44221
  • Agency: PHS HHS, United States
    Id: 32111-13
  • Agency: WHI NIH HHS, United States
    Id: N01WH22110

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Institute of Bioinformatics and Systems Biology; Neuherberg; Germany (tool)

RRID:SCR_011307

Hosts the Munich Information Center for Protein Sequences (MIPS) and its main focus is the genome-oriented bioinformatics, in particular the systematic analysis of genome information including the development and application of bioinformatics methods in genome annotation, expression analysis and proteomics. MIPS supports and maintains a set of generic databases as well as the systematic comparative analysis of microbial, fungal, and plant genomes.

View all literature mentions